Medicine and Dentistry
Reflux
100%
Gastroesophageal Reflux
57%
Hepatitis B
32%
Esophagus Function
31%
Volunteer
31%
Hepatitis C Virus
30%
Hepatitis B Virus
29%
Chronic Hepatitis B
26%
Retrospective Cohort Study
26%
Liver Fibrosis
26%
Emergency Department
26%
Liver Toxicity
26%
Low and Middle Income Countries
26%
Methotrexate
26%
Hepatitis delta virus
26%
Lymphogranuloma Venereum
26%
Gaviscon
26%
High Resolution Manometry
26%
Hepatitis C
26%
Patient Characteristics
26%
Virus Infection
26%
Test Meal
26%
Proctitis
26%
Antacid
26%
Alginic Acid
26%
Cohort Effect
26%
Magnetic Resonance Imaging
26%
Inflammatory Bowel Disease
26%
Gene Linkage
17%
Public Health
15%
Esophageal pH Monitoring
13%
False Negative Result
13%
Positive Syndrome
13%
Antireflux Operation
13%
Diagnostic Test
13%
Prevalence
12%
Manometry
12%
Procollagen
12%
Medicine
10%
Body Mass Index
10%
Lower Esophagus Sphincter Pressure
10%
Sphincter
10%
Clinical Management
9%
Hepatitis Virus
8%
Electronic Patient Record
8%
Care Pathway
8%
Mixed Infection
8%
Hepatitis B(e) Antigen
8%
Hepatitis B Antigen
8%
Blood Borne Virus
8%
Pharmacology, Toxicology and Pharmaceutical Science
Gastroesophageal Reflux
58%
Hepatitis C Virus
30%
Liver Fibrosis
26%
Hepatitis Delta Virus
26%
Cohort Study
26%
Chronic Hepatitis B
26%
Methotrexate
26%
Gaviscon
26%
Hepatotoxicity
26%
Virus Infection
26%
Antacid Agent
26%
Normal Human
26%
Antiviral Drug
26%
Clinical Trial
26%
Alginic Acid
26%
Infection
26%
Ribavirin
26%
Chronic Hepatitis C
26%
Interferon
17%
Side Effect
17%
Liver Disease
17%
Prevalence
16%
Positive Syndrome
13%
Abdominal Obesity
13%
Procollagen
12%
Hepatitis B Virus
12%
Hepatitis B(e) Antigen
8%
Mixed Infection
8%
Cyclophilin Inhibitor
8%
Hepatitis C
8%
Serine Proteinase Inhibitor
8%
Antiviral Activity
8%
Virotherapy
8%
Observational Study
8%
Telaprevir
8%
Boceprevir
8%
Hepatitis C Virus Genotype 1
8%
Gastrointestinal Disease
8%
Peginterferon
8%
Fibrosis
8%
HIV
7%
Liver Cirrhosis
7%
Hepatitis B
6%
Psoriasis
6%
Clinical Study
5%
Immunology and Microbiology
Hepatitis B
85%
Hepatitis B Virus
42%
Hepatitis C Virus
32%
Serology
29%
Viral Disease
26%
Hepatitis delta virus
26%
Hepatitis C
26%
Human immunodeficiency virus
14%
Hepatitis B(e) Antigen
13%
Coinfection
13%
Hepatitis Virus
10%
HBsAg
8%
Blood Borne Virus
8%
Hepatitis B Antigen
8%
Electronic Patient Record
8%
Hepatitis B Surface Antibody
8%
Prevalence
7%
Awareness
6%
Antiviral Resistance
6%
Promoter Region
6%
Disease Burden
6%
Hepatitis B Vaccine
5%